Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

Acutely ill medical patients are at risk of venous thromboembolism (VTE) and VTE-related mortality during hospitalization and posthospital discharge, but widespread adoption of extended thromboprophylaxis has not occurred. We analyzed a subpopulation within the MAGELLAN study of extended thromboprop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Appl Thromb Hemost
Hlavní autoři: Spyropoulos, Alex C., Lipardi, Concetta, Xu, Jianfeng, Lu, Wentao, Suh, Eunyoung, Yuan, Zhong, Levitan, Bennett, Sugarmann, Chiara, De Sanctis, Yoriko, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary E.
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7019408/
https://ncbi.nlm.nih.gov/pubmed/31746218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619886022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky